Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06069141Recruiting
Randomised, open-label trial of doxycycline in syphilis (2 arms), sponsored by National Taiwan University Hospital. Primary endpoint: Serologic response at 48 weeks. Started Jan 2024; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06069141.